Integrilin
Active substance: eptifibatide
eptifibatide
Centralised EU authorisationWithdrawn
Marketing holder: GlaxoSmithKline Trading Services Limited
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 7 |
|
| US 21 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-adb6-7818-9fbd-67bb1a155ce0,01a120c3-bf06-7eb2-be30-d88b08f6840d,01a120c4-baf0-79a5-b371-2b5f56a19e81,01a120c5-8467-78c4-8ef8-52f37781cb03,01a120c5-c68a-7f8d-80e1-c94c5e025cb2;count=7 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-291a-79b2-86e3-2fe903a0d66e,01a1208c-b5f9-7a23-9daf-1ee2a037af00,01a1208d-3d40-7a64-9afb-b7a0162f6647,01a1208d-a12f-75f6-84c1-499e14826fe5,01a1208e-76e1-7dbe-b486-f076327f389e;count=21 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/000230
- Registration status
- Withdrawn
- ATC code
- B01AC16
- product · EMA · EMEA/H/C/000230 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000230 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000230 · Verified 2026-10-09